✦ LIBER ✦

P115 LONG-TERM EPISODIC INFLIXIMAB TREATMENT IN CROHN'S DISEASE. A DANISH CROHN COLITIS DATABASE STUDY

✍ Scribed by N. Pedersen; S. Caspersen; C. Mortensen; M. Elkjær; L. Riis; V. Wewer; P. Munkholm

Book ID: 119637102
Publisher: Oxford University Press
Year: 2007
Weight: 60 KB
Volume: 1
Category: Article
ISSN: 1873-9954
DOI: 10.1016/s1873-9954(07)70127-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Aminosalicylic acid dependency in Croh

5-Aminosalicylic acid dependency in Crohn's disease: A Danish Crohn Colitis Database study

✍ Dana Duricova; Natalia Pedersen; Margarita Elkjaer; Jens K. Slott Jensen; Pia Mu 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 466 KB

63 P Long term infliximab treatment of a

63 P Long term infliximab treatment of a unconventional esophageal Crohn's disease

✍ F. Morace; A. Marone; R. Pumpo; A. Savastano; G. Marone 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

P234 IS THERE AN ASSOCIATION BETWEEN C-R

P234 IS THERE AN ASSOCIATION BETWEEN C-REACTIVE PROTEIN LEVEL AND INFLIXIMAB DEPENDENCY IN CROHN'S DISEASE? A DCCD, DANISH CROHN COLITIS DATABASE STUDY

✍ V. Giannelli; D. Duricova; N. Pedersen; M. Elkjaer; P. Munkholm 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 70 KB

P.01.20 SAFETY OF LONG-TERM INFLIXIMAB A

P.01.20 SAFETY OF LONG-TERM INFLIXIMAB AND ADALIMUMAB TREATMENTS IN CROHN'S DISEASE

✍ Mazzuoli, S.; Regano, N.; Guglielmi, F.W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P470 Infliximab treatment for paediatric

P470 Infliximab treatment for paediatric Crohn's disease: long-term outcomes at a single centre

✍ Church, P.; Guan, J.; Frost, K.; Muise, A.; Walters, T.; Griffiths, A. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 125 KB

Long-term outcome of treatment with infl

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

✍ Valérie Crombé; Julia Salleron; Guillaume Savoye; Jean-Louis Dupas; Gwénola Vern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Background: We examined short-and long-term benefits and safety of infliximab (IFX) in a population-based cohort of Crohn's disease (CD) patients <17 years old at diagnosis. ## Methods: The following parameters were assessed: short-and long-term efficacy of IFX, impact of drug efficacy, and mode